Bipolar Disorder and Treatment Market 2027 By Type, By Drug Class, By Mechanism of Action, By Treatment and Geography | The Insight Partners

Bipolar Disorder and Treatment Market to 2027 - Global Analysis and Forecasts by Type (Bipolar I, Bipolar II, Cyclothymia); By Drug Class (Anticonvulsants, Antianxiety, Mood Stabilizers, Antipsychotic, Antidepressant); By Mechanism of Action (Monoamine oxidase inhibitors, Serotonin-norepinephrine reuptake inhibitors, Selective serotonin reuptake inhibitors, Beta blockers, Tricyclic antidepressants, Benzodiazepines); By Treatment (ECT (Electroconvulsive Therapy), TMS (Transcranial magnetic stimulation), Others (Psychotic therapies)) and Geography

Report Code: TIPRE00004576 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Bipolar disorder is known as manic depression is a mental disorder that could lead to periods of depression and elevated mood.it has been term as biopolar due to the extreme changes or two different sides that the person suffer in the disease. The present research have found that it is a genetic disease and is transferred through genes. There are certain genes responsible for the development of said disease.

MARKET DYNAMICS
The bipolar disorder and treatment market is expected to grow during the forecast period due to increasing stressful adults, change in life style, increasing high demand of anti-depressants and advance in combination drug therapeutic market will boost the global market of bipolar disorder and treatment. Furthermore increase awareness in the healthcare and government taking step is create growth opportunities for the global market during forecast period.

MARKET SCOPE
The "Global Bipolar Disorder and Treatment Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of bipolar disorder with detailed market segmentation by product type, drug class, mechanism of action, treatment and geography. The global bipolar disorder and treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading bipolar disorder and treatment Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global bipolar disorder and treatment market is segmented on the basis of product type, drug class, mechanism of action, and treatment. Based on products type, the market is segmented bipolar -1, bipolar-2, bipolar -3.On the basis of drug class, the global bipolar disorder and treatment market is segmented into monoamine oxidase inhibitor, serotonin norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitor, beta blockers, tricyclic antidepressant, and benzodiazepines. Based on treatment the market is segmented as ETC, TMS and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bipolar disorder and treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bipolar disorder and treatment by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bipolar disorder and treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bipolar disorder and treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the bipolar disorder and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bipolar disorder and treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for bipolar disorder and treatment in the global market. Below mentioned is the list of few companies engaged in the Asthma therapeutics market.

The report also includes the profiles of key bipolar disorder and treatment companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Astellas Pharma Inc.
  • Allergan Plc.
  • GlaxoSmithKline Plc.
  • AbbVie Inc.
  • Pfizer, Inc.
  • Johnson and Johnson Services, Inc.
  • Novartis AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bipolar Disorder And Treatment Market - By Type
1.3.2 Bipolar Disorder And Treatment Market - By Drug Class
1.3.3 Bipolar Disorder And Treatment Market - By Mechanism of Action
1.3.4 Bipolar Disorder And Treatment Market - By Treatment
1.3.5 Bipolar Disorder And Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIPOLAR DISORDER AND TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIPOLAR DISORDER AND TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIPOLAR DISORDER AND TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BIPOLAR DISORDER AND TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BIPOLAR DISORDER AND TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIPOLAR DISORDER AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - BY TYPE
7.1. OVERVIEW
7.2. BY TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIPOLAR I
7.3.1. Overview
7.3.2. Bipolar I Market Forecast and Analysis
7.4. BIPOLAR II
7.4.1. Overview
7.4.2. Bipolar II Market Forecast and Analysis
7.5. CYCLOTHYMIA
7.5.1. Overview
7.5.2. Cyclothymia Market Forecast and Analysis
8. BIPOLAR DISORDER AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - BY DRUG CLASS
8.1. OVERVIEW
8.2. BY DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. ANTICONVULSANTS
8.3.1. Overview
8.3.2. Anticonvulsants Market Forecast and Analysis
8.4. ANTIANXIETY
8.4.1. Overview
8.4.2. Antianxiety Market Forecast and Analysis
8.5. MOOD STABILIZERS
8.5.1. Overview
8.5.2. Mood Stabilizers Market Forecast and Analysis
8.6. ANTIPSYCHOTIC
8.6.1. Overview
8.6.2. Antipsychotic Market Forecast and Analysis
8.7. ANTIDEPRESSANT
8.7.1. Overview
8.7.2. Antidepressant Market Forecast and Analysis
9. BIPOLAR DISORDER AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - BY MECHANISM OF ACTION
9.1. OVERVIEW
9.2. BY MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. MONOAMINE OXIDASE INHIBITORS
9.3.1. Overview
9.3.2. Monoamine oxidase inhibitors Market Forecast and Analysis
9.4. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
9.4.1. Overview
9.4.2. Serotonin-norepinephrine reuptake inhibitors Market Forecast and Analysis
9.5. SELECTIVE SEROTONIN REUPTAKE INHIBITORS
9.5.1. Overview
9.5.2. Selective serotonin reuptake inhibitors Market Forecast and Analysis
9.6. BETA BLOCKERS
9.6.1. Overview
9.6.2. Beta blockers Market Forecast and Analysis
9.7. TRICYCLIC ANTIDEPRESSANTS
9.7.1. Overview
9.7.2. Tricyclic antidepressants Market Forecast and Analysis
9.8. BENZODIAZEPINES
9.8.1. Overview
9.8.2. Benzodiazepines Market Forecast and Analysis
10. BIPOLAR DISORDER AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - BY TREATMENT
10.1. OVERVIEW
10.2. BY TREATMENT MARKET FORECASTS AND ANALYSIS
10.3. ECT (ELECTROCONVULSIVE THERAPY)
10.3.1. Overview
10.3.2. ECT (Electroconvulsive therapy) Market Forecast and Analysis
10.4. TMS (TRANSCRANIAL MAGNETIC STIMULATION)
10.4.1. Overview
10.4.2. TMS (Transcranial magnetic stimulation) Market Forecast and Analysis
10.5. OTHERS (PSYCHOTIC THERAPIES)
10.5.1. Overview
10.5.2. Others (Psychotic therapies) Market Forecast and Analysis
11. BIPOLAR DISORDER AND TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Bipolar Disorder And Treatment Market Overview
11.1.2 North America Bipolar Disorder And Treatment Market Forecasts and Analysis
11.1.3 North America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Type
11.1.4 North America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Drug Class
11.1.5 North America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Mechanism of Action
11.1.6 North America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Treatment
11.1.7 North America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Bipolar Disorder And Treatment Market
11.1.7.1.1 United States Bipolar Disorder And Treatment Market by Type
11.1.7.1.2 United States Bipolar Disorder And Treatment Market by Drug Class
11.1.7.1.3 United States Bipolar Disorder And Treatment Market by Mechanism of Action
11.1.7.1.4 United States Bipolar Disorder And Treatment Market by Treatment
11.1.7.2 Canada Bipolar Disorder And Treatment Market
11.1.7.2.1 Canada Bipolar Disorder And Treatment Market by Type
11.1.7.2.2 Canada Bipolar Disorder And Treatment Market by Drug Class
11.1.7.2.3 Canada Bipolar Disorder And Treatment Market by Mechanism of Action
11.1.7.2.4 Canada Bipolar Disorder And Treatment Market by Treatment
11.1.7.3 Mexico Bipolar Disorder And Treatment Market
11.1.7.3.1 Mexico Bipolar Disorder And Treatment Market by Type
11.1.7.3.2 Mexico Bipolar Disorder And Treatment Market by Drug Class
11.1.7.3.3 Mexico Bipolar Disorder And Treatment Market by Mechanism of Action
11.1.7.3.4 Mexico Bipolar Disorder And Treatment Market by Treatment
11.2. EUROPE
11.2.1 Europe Bipolar Disorder And Treatment Market Overview
11.2.2 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis
11.2.3 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis - By Type
11.2.4 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis - By Drug Class
11.2.5 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis - By Mechanism of Action
11.2.6 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis - By Treatment
11.2.7 Europe Bipolar Disorder And Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Bipolar Disorder And Treatment Market
11.2.7.1.1 Germany Bipolar Disorder And Treatment Market by Type
11.2.7.1.2 Germany Bipolar Disorder And Treatment Market by Drug Class
11.2.7.1.3 Germany Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.1.4 Germany Bipolar Disorder And Treatment Market by Treatment
11.2.7.2 France Bipolar Disorder And Treatment Market
11.2.7.2.1 France Bipolar Disorder And Treatment Market by Type
11.2.7.2.2 France Bipolar Disorder And Treatment Market by Drug Class
11.2.7.2.3 France Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.2.4 France Bipolar Disorder And Treatment Market by Treatment
11.2.7.3 Italy Bipolar Disorder And Treatment Market
11.2.7.3.1 Italy Bipolar Disorder And Treatment Market by Type
11.2.7.3.2 Italy Bipolar Disorder And Treatment Market by Drug Class
11.2.7.3.3 Italy Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.3.4 Italy Bipolar Disorder And Treatment Market by Treatment
11.2.7.4 Spain Bipolar Disorder And Treatment Market
11.2.7.4.1 Spain Bipolar Disorder And Treatment Market by Type
11.2.7.4.2 Spain Bipolar Disorder And Treatment Market by Drug Class
11.2.7.4.3 Spain Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.4.4 Spain Bipolar Disorder And Treatment Market by Treatment
11.2.7.5 United Kingdom Bipolar Disorder And Treatment Market
11.2.7.5.1 United Kingdom Bipolar Disorder And Treatment Market by Type
11.2.7.5.2 United Kingdom Bipolar Disorder And Treatment Market by Drug Class
11.2.7.5.3 United Kingdom Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.5.4 United Kingdom Bipolar Disorder And Treatment Market by Treatment
11.2.7.6 Rest of Europe Bipolar Disorder And Treatment Market
11.2.7.6.1 Rest of Europe Bipolar Disorder And Treatment Market by Type
11.2.7.6.2 Rest of Europe Bipolar Disorder And Treatment Market by Drug Class
11.2.7.6.3 Rest of Europe Bipolar Disorder And Treatment Market by Mechanism of Action
11.2.7.6.4 Rest of Europe Bipolar Disorder And Treatment Market by Treatment
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Bipolar Disorder And Treatment Market Overview
11.3.2 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis - By Drug Class
11.3.5 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis - By Mechanism of Action
11.3.6 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis - By Treatment
11.3.7 Asia-Pacific Bipolar Disorder And Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Bipolar Disorder And Treatment Market
11.3.7.1.1 Australia Bipolar Disorder And Treatment Market by Type
11.3.7.1.2 Australia Bipolar Disorder And Treatment Market by Drug Class
11.3.7.1.3 Australia Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.1.4 Australia Bipolar Disorder And Treatment Market by Treatment
11.3.7.2 China Bipolar Disorder And Treatment Market
11.3.7.2.1 China Bipolar Disorder And Treatment Market by Type
11.3.7.2.2 China Bipolar Disorder And Treatment Market by Drug Class
11.3.7.2.3 China Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.2.4 China Bipolar Disorder And Treatment Market by Treatment
11.3.7.3 India Bipolar Disorder And Treatment Market
11.3.7.3.1 India Bipolar Disorder And Treatment Market by Type
11.3.7.3.2 India Bipolar Disorder And Treatment Market by Drug Class
11.3.7.3.3 India Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.3.4 India Bipolar Disorder And Treatment Market by Treatment
11.3.7.4 Japan Bipolar Disorder And Treatment Market
11.3.7.4.1 Japan Bipolar Disorder And Treatment Market by Type
11.3.7.4.2 Japan Bipolar Disorder And Treatment Market by Drug Class
11.3.7.4.3 Japan Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.4.4 Japan Bipolar Disorder And Treatment Market by Treatment
11.3.7.5 South Korea Bipolar Disorder And Treatment Market
11.3.7.5.1 South Korea Bipolar Disorder And Treatment Market by Type
11.3.7.5.2 South Korea Bipolar Disorder And Treatment Market by Drug Class
11.3.7.5.3 South Korea Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.5.4 South Korea Bipolar Disorder And Treatment Market by Treatment
11.3.7.6 Rest of Asia-Pacific Bipolar Disorder And Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Bipolar Disorder And Treatment Market by Type
11.3.7.6.2 Rest of Asia-Pacific Bipolar Disorder And Treatment Market by Drug Class
11.3.7.6.3 Rest of Asia-Pacific Bipolar Disorder And Treatment Market by Mechanism of Action
11.3.7.6.4 Rest of Asia-Pacific Bipolar Disorder And Treatment Market by Treatment
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Bipolar Disorder And Treatment Market Overview
11.4.2 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis - By Drug Class
11.4.5 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis - By Mechanism of Action
11.4.6 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis - By Treatment
11.4.7 Middle East and Africa Bipolar Disorder And Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Bipolar Disorder And Treatment Market
11.4.7.1.1 South Africa Bipolar Disorder And Treatment Market by Type
11.4.7.1.2 South Africa Bipolar Disorder And Treatment Market by Drug Class
11.4.7.1.3 South Africa Bipolar Disorder And Treatment Market by Mechanism of Action
11.4.7.1.4 South Africa Bipolar Disorder And Treatment Market by Treatment
11.4.7.2 Saudi Arabia Bipolar Disorder And Treatment Market
11.4.7.2.1 Saudi Arabia Bipolar Disorder And Treatment Market by Type
11.4.7.2.2 Saudi Arabia Bipolar Disorder And Treatment Market by Drug Class
11.4.7.2.3 Saudi Arabia Bipolar Disorder And Treatment Market by Mechanism of Action
11.4.7.2.4 Saudi Arabia Bipolar Disorder And Treatment Market by Treatment
11.4.7.3 U.A.E Bipolar Disorder And Treatment Market
11.4.7.3.1 U.A.E Bipolar Disorder And Treatment Market by Type
11.4.7.3.2 U.A.E Bipolar Disorder And Treatment Market by Drug Class
11.4.7.3.3 U.A.E Bipolar Disorder And Treatment Market by Mechanism of Action
11.4.7.3.4 U.A.E Bipolar Disorder And Treatment Market by Treatment
11.4.7.4 Rest of Middle East and Africa Bipolar Disorder And Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Bipolar Disorder And Treatment Market by Type
11.4.7.4.2 Rest of Middle East and Africa Bipolar Disorder And Treatment Market by Drug Class
11.4.7.4.3 Rest of Middle East and Africa Bipolar Disorder And Treatment Market by Mechanism of Action
11.4.7.4.4 Rest of Middle East and Africa Bipolar Disorder And Treatment Market by Treatment
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Bipolar Disorder And Treatment Market Overview
11.5.2 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis
11.5.3 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Type
11.5.4 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Drug Class
11.5.5 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Mechanism of Action
11.5.6 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Treatment
11.5.7 South and Central America Bipolar Disorder And Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Bipolar Disorder And Treatment Market
11.5.7.1.1 Brazil Bipolar Disorder And Treatment Market by Type
11.5.7.1.2 Brazil Bipolar Disorder And Treatment Market by Drug Class
11.5.7.1.3 Brazil Bipolar Disorder And Treatment Market by Mechanism of Action
11.5.7.1.4 Brazil Bipolar Disorder And Treatment Market by Treatment
11.5.7.2 Argentina Bipolar Disorder And Treatment Market
11.5.7.2.1 Argentina Bipolar Disorder And Treatment Market by Type
11.5.7.2.2 Argentina Bipolar Disorder And Treatment Market by Drug Class
11.5.7.2.3 Argentina Bipolar Disorder And Treatment Market by Mechanism of Action
11.5.7.2.4 Argentina Bipolar Disorder And Treatment Market by Treatment
11.5.7.3 Rest of South and Central America Bipolar Disorder And Treatment Market
11.5.7.3.1 Rest of South and Central America Bipolar Disorder And Treatment Market by Type
11.5.7.3.2 Rest of South and Central America Bipolar Disorder And Treatment Market by Drug Class
11.5.7.3.3 Rest of South and Central America Bipolar Disorder And Treatment Market by Mechanism of Action
11.5.7.3.4 Rest of South and Central America Bipolar Disorder And Treatment Market by Treatment
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BIPOLAR DISORDER AND TREATMENT MARKET, KEY COMPANY PROFILES
13.1 AstraZeneca
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BMS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3 Eli-Lilly and Company
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ALLERGAN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JANSSEN PHARMACEUTICALS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PFIZER, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NOVARTIS AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABBVIE INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ABBOTT
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. MERCK KGAA
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. TEVA PHARMACEUTICAL INDUSTRIES LTD
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. SUMITOMO DAINIPPON PHARMA CO. LTD
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
13.14. ASTELLAS PHARMA INC
13.14.1. Key Facts
13.14.2. Business Description
13.14.3. Products and Services
13.14.4. Financial Overview
13.14.5. SWOT Analysis
13.14.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Bristol-Myers Squibb Company
3. Eli Lilly and Company
4. Astellas Pharma Inc
5. Allergan plc
6. GlaxoSmithKline plc
7. AbbVie Inc
8. Pfizer Inc
9. Johnson and Johnson
10. Novartis AG